# Whole-Food Dietary Interventions in Crohn’s Disease: A Literature Review

**Authors:** Abdulrahman Al-Majmuei, Farah Fakhri, Lyaba Imran

PMC · DOI: 10.7759/cureus.103488 · Cureus · 2026-02-12

## TL;DR

This review explores recent whole-food diets for managing Crohn’s disease, focusing on their impact on symptoms, gut health, and long-term outcomes.

## Contribution

The paper provides a critical evaluation of emerging dietary interventions for Crohn’s disease in the last five years.

## Key findings

- Whole-food diets like the Mediterranean and low-FODMAP diets show promise in improving clinical outcomes.
- Dietary interventions can influence gut microbiota and mucosal integrity in Crohn’s disease patients.
- Personalized nutrition and integration with pharmacologic therapy are highlighted as future directions.

## Abstract

This narrative review examines advances in diet-based therapy for Crohn’s disease with a focus on emerging whole-food interventions that have gained attention in the past five years. The aim is to evaluate the current evidence for the Crohn’s disease exclusion diet, specific carbohydrate diet, Mediterranean diet, and newer approaches such as CD-TREAT (Crohn’s disease treatment with eating diet), low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) strategies, and plant-based regimens. Drawing on recent randomised controlled trials and mechanistic studies, this review explores how these diets influence clinical outcomes, gut microbiota composition, and mucosal integrity, while identifying limitations, controversies, and gaps in knowledge. In addition to summarising the latest findings, we offer a critical perspective on the potential for personalised nutrition, the integration of diet with pharmacologic therapy, and the need for long-term maintenance studies. The scope is limited to mild-to-moderate Crohn’s disease, reflecting the clinical scenarios where dietary interventions are most often applied. This review emphasises the potential for diet to function as a structured therapeutic intervention aligned with patient preferences, provided it is implemented within multidisciplinary care models to ensure efficacy, safety, and sustainability.

## Linked entities

- **Diseases:** Crohn’s disease (MONDO:0005011)

## Full-text entities

- **Diseases:** Crohn's Disease (MESH:D003424)
- **Chemicals:** disaccharides (MESH:D004187), monosaccharides (MESH:D009005), polyols (MESH:C024617), carbohydrate (MESH:D002241), oligosaccharides (MESH:D009844)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12988833/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12988833/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12988833/full.md

---
Source: https://tomesphere.com/paper/PMC12988833